We have invested several hundred million dollars in Research and Development to develop our portfolio assets, and to create commercial scale manufacturing capacities to address global volume requirements across multiple manufacturing platforms. Our strength in R&D, with a clearly defined vision, diverse talent pool and innovative platform technologies, has resulted in affordable and quality therapies for patients across the globe. At Biocon, R&D in conjugation with innovation and collaboration, is set to redefine the success path. This, in turn, will complement our in-house capabilities for enabling access to affordable healthcare for patients, partners and healthcare systems across the globe.